This episode is brought to you by Slack. With Slack, you can bring all your people and

tools together in one place. It's your digital HQ where you can increase productivity,

enable flexibility and automate workflows. Plus, Slack is full of game-changing features

like huddles for quick check-ins or Slack Connect, which helps you connect with partners

inside and outside of your company. Slack, where the future works. Get started at

Slack.com slash DHQ. Washington and its allies ready additional sanctions on Russia. Plus,

we'll go inside the push to supply Ukraine with counter drone systems and look at why the

FDA is pressing pause on an increasing number of clinical trials.

One of the reasons the agency thinks they may have gone up is because of an increase

in cutting-edge gene therapies, treating all kinds of challenging diseases because the technology

is don't new.

It's Wednesday, January 11th. I'm Luke Vargas with Wall Street Journal and here's the

AM edition of What's News, the top headlines and business stories moving your world today.

The United States and its allies are preparing fresh sanctions on the Russian oil industry.

Those discussions taking place in meetings across Europe this week follow new limits that

were placed on Russian crude exports last month. Wall Street Journal reporter Julie Steinberg

has more.

The AM is to cap the sales price of Russian exports of refined petroleum and the penalties

will set two price limits on Russian refined products. One on high-value exports such as

diesel and another on low-value ones such as fuel oil that's according to people familiar

with the plans. The penalties on our fine products could trigger economic consequences globally.

Market watchers and some Western officials expect that Russia will have a harder time

...